Dr. Constantine G. Lyketsos, MD

Dr. Lyketsos practices at Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System.

Dr. Lyketsos' NPI, 1306881909, was assigned on June 18, 2006. Dr. Lyketsos graduated from WashU Medicine in 1988. Dr. Lyketsos holds Maryland license D38790.

Dr. Lyketsos' primary practice is Johns Hopkins Bayview Medical Center, at 4940 Eastern Avenue, Baltimore, MD 21224 in Baltimore City. The practice phone is (410) 550-0123.

Dr. Lyketsos' primary practice is Johns Hopkins Bayview Medical Center in Baltimore, Maryland, part of Johns Hopkins Health System. Dr. Lyketsos is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lyketsos practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Lyketsos' primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Lyketsos is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Lyketsos' licenses on file in 3 states: Maryland, Florida and Virginia.

Dmand AI lists bipolar disorder, depression, insomnia, non-alzheimer's dementia (chronic), psychoses and tobacco use among the conditions Dr. Lyketsos treats.

CMS data shows 206 Medicare services from Dr. Lyketsos across 6 procedure codes in 2024, for 152 Medicare patients. Medicare paid $19,191 for them.

CMS counts 152 Medicare patients who saw Dr. Lyketsos in 2024. The largest group is 75 to 84, with 94 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lyketsos' median patient age at 80, with 47% women.

In 2024, Dr. Lyketsos wrote 357 Medicare Part D claims for 63 patients. 89% of them were for generic drugs. CMS names the drug for 280 of them, across 12 drugs with 11 or more claims each, at $46,748 in total drug cost. In 2023, CMS named 337 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Lyketsos for performance year 2024, reported as part of a group. CMS lists Dr. Lyketsos as offering telehealth.

Dmand AI links 425 papers to Dr. Lyketsos, published from 2005 to 2025. 2019 was the busiest year, with 19. The most frequent topics are Alzheimer Disease, Dementia and Neuropsychological Tests. Dr. Lyketsos has published most often in Int J Geriatr Psychiatry. Dr. Lyketsos' most frequent co-authors are Peter V. Rabins, MD, Michelle M. Mielke, MD and Jacobo Enrique Mintzer, MD.

Dmand AI links Dr. Lyketsos to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Psychomotor Agitation, Psychomotor Disorders and Caregiver Burden. Johns Hopkins University sponsors the most, 3. Open Payments lists research payments to Dr. Lyketsos that name 1 trial.

CMS Open Payments shows 51 general payments to Dr. Lyketsos from 11 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 63% of the total. Genentech, Inc. paid the most, $15,664. It also lists 5 research payments totaling $1,246 in 2017, naming 1 clinical trial.

Dmand AI lists 23 awards for Dr. Lyketsos, most recently America's Top Doctors in 2023.

Dr. Lyketsos graduated from WashU Medicine in 1988.

Dr. Lyketsos is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.